Perfluorochemicals and hyperbaric oxygen in radiation therapy.

Area of Science:

• Oncology
• Radiation Oncology
• Biomedical Engineering

Background:

• Tumor hypoxia, characterized by low oxygen levels, reduces radiation sensitivity and curability.
• Hyperbaric oxygen therapy (HBOT) aims to improve tumor oxygenation but has shown limited clinical success.
• The diffusion of oxygen in tumors is limited by capillary partial pressure and consumption.

Purpose of the Study:

• To evaluate the theoretical effectiveness of hyperbaric oxygen in improving tumor oxygenation.
• To explore the potential of perfluorocarbon micelles in enhancing oxygen delivery to tumors.
• To investigate novel strategies for overcoming tumor hypoxia in radiation therapy.

Main Methods:

• Theoretical modeling of oxygen diffusion in tumors under varying oxygen pressures.
• Analysis of oxygen partial pressure (PartO2) in capillaries and tumor tissues.
• Inclusion of perfluorocarbon micelles to increase blood oxygen-carrying capacity.

Main Results:

• Hyperbaric oxygen at 3 ATA provides only marginal improvement in tumor oxygenation.
• Oxygen partial pressure at the capillary venous end remains suboptimal with HBOT.
• Perfluorocarbon micelles significantly increase non-hemoglobin-bound oxygen, improving oxygen delivery throughout capillaries.

Conclusions:

• The limited success of HBOT is explained by insufficient oxygen delivery to hypoxic tumor regions.
• Perfluorocarbon micelles offer a theoretical advantage by increasing oxygen carrying capacity and diffusion.
• This approach demonstrates potential for improving tumor oxygenation and radiation therapy efficacy, as shown in a rodent model.